Jeff Geschwind, MD & Non-Invasive Cancer Therapy Jeff Geschwind, MD advises HistoSonics, a company revolutionizing liver cancer treatment with non-invasive, image-guided ablation. His contributions support breakthrough technologies that destroy tumors without surgery, reducing recovery times. https://www.bumc.bu.edu/camed/jean-francois-jeff-geschwind-m-d-91-2011-distinguished-alumnus-award/